Skip to main content

Advertisement

Log in

Uveitis associated with sarcoidosis exacerbated by etanercept therapy

  • Letters
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Galor A, Perez VL, Hammel JP, et al. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmol 2003;113:2317–2323.

    Article  Google Scholar 

  2. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 2007;56:3248–3252.

    Article  PubMed  CAS  Google Scholar 

  3. Hashkes PJ, Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol 2003;21:645–646.

    PubMed  CAS  Google Scholar 

  4. Prasse A, Georges CG, Biller H, et al. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 2000;122:241–248.

    Article  PubMed  CAS  Google Scholar 

  5. Sieper J, Van den Brande J. Diverse effects of infliximab and etanercept on T lymphocytes. Semin Arthritis Rheum 2005;34:23–27.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun Suzuki.

About this article

Cite this article

Suzuki, J., Goto, H. Uveitis associated with sarcoidosis exacerbated by etanercept therapy. Jpn J Ophthalmol 53, 439–440 (2009). https://doi.org/10.1007/s10384-009-0691-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-009-0691-6

Key Words

Navigation